
CatalogNo.:57005
Size:100ulpurifiedrabbitimmunoglobulininphosphate-bufferedsaline,pH7.0,0.09%sodiumazideand50%glycerol.
BACKGROUNDAmyloidmonomericproteinscanoligomerizeintodestructiveamyloidfibrils.Amyloidogenicconformationsofnon-diseaserelatedproteinscanbecreatedbypartialproteinmisfoldingordenaturation.Manydegenerativediseasesareknowntoberelatedtotheaccumulationofmisfoldedproteinsasamyloidfibers.Theseincludetheamyloid-βpeptideplaquesandtauneurofibrillarytanglesinsenileplaquesofAlzheimer’ssymptomology,thedepositionofα-synucleinintheLewybodiesofParkinson’sdisease,andaccumulationofpolyglutamine-containingaggregatesinHuntington’sdisease.
SPECIFICATIONSUMMARYAntigen:FibrilspreparedfromhumanAβ42peptide.
HostSpecies:Rabbit
AntibodyClass:Polyclonal
Thisantibodyrecognizesepitopescommontomanyhumanamyloidfibrilsandfibrillaroligomersbutnotprefibrillaroligomersornativelyfoldedproteins.Predictedtorecognizemouseandratbasedonsequencehomology.
Forinvitroinvestigationaluseonly.Notforuseintherapeuticordiagnosticprocedures.
APPLICATIONSImmunoblotting:useat1:1,000dilution.
Dotblot:useat1:1,000dilution.
DotblotanalysisofAβ42andpolyQ36prefibrillaroligomersandfibrils.Aβ42andpolyQfibrilsstainwith
#57005serum,whileAβ42andpolyQprefibrillaroligomersreactwith#57006(A11).
Immunohistochemistry:useat1:1,000dilution.
Labelingofamyloidfibrilswasobservedinthehippocampus(A),subiculum(B)andfrontalcortex(C)inAlzheimerdisease.Ahighermagnificationphotographillustratesthatamyloidfibrildepositsweredenseandconsistedoffinefibrillarmaterial(D).
ELISA:useat1:1,000dilutionwithamyloidfibril-containingsamplesonthesolidphase.Thesearerecommendedconcentrations.
Endusershoulddetermineoptimalconcentrationsfortheirapplications.
DiluteinPBSormediumwhichisidenticaltothatusedintheassaysystem.
Thisproductisstableforatleast1yearat
-20oC.Freezeinmultiplealiquotstoavoidrepeatedfreeze-thawcycles.